Home » FDA Clears Abiomed’s Impella Heart Pumps for Emergency Use
FDA Clears Abiomed’s Impella Heart Pumps for Emergency Use
The FDA has issued an Emergency Use Authorization for Abiomed’s left-sided Impella heart pumps, allowing the devices to be used for support of COVID-19 patients.
The device supports individuals undergoing extracorporeal membrane oxygenation therapy, a treatment that circulates blood through an artificial lung back into the patient.
The pumps received a premarket approval from the FDA in 2015.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May